During the past decade, University of Southern California conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Southern California" #1 collaborator was "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "University of Southern California" are "HIV Infection" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "University of Southern California" in a lesser frequency.

Most popular intervention types in "University of Southern California" are "Behavioral" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "All licensed antiretroviral medications" (1 trials) and "Pathways" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Southern California" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Southern California". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Southern California, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Southern California, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".